[28] | 2013-2014 | Trinidad | Prospective, observational | Hospital | To obtain overview on MRSA and MSSA clinical isolates and characterize them by microarray hybridization and by multi locus sequence typing (MLST) |
[29] | 2016 | Northern region of Trinidad and Tobago | Retrospective, observational | Rural Community | To delineate the SCCmec type and toxin genes, and genes mediating antibiotic resistance in MRSA isolates |
[30] | 2011 | Cuba | Retrospective, observational (Epidemiological analysis) | Hospital | To characterize MRSA isolates recovered from Cuban hospitals by a variety of methods |
[31] | 2012 | Haiti | Cross-sectional analysis | Community | To describe the molecular epidemiology of nasal carriage isolates of S. aureus. |
[32] | 2017-2018 | St. Kitts | Prospective, observational | Hospital | To determine the prevalence of antimicrobial resistance among S. aureus isolates and to reveal the frequency and population structure of MRSA in St. Kitts and Nevis |
[33] | 2013 | Trinidad and Tobago | Prospective, observational | Hospital | To assess the prevalence of MRSA in patients hospitalized in the surgical wards of, and determine associated risk factors |
[34] | 2008 | Jamaica | Prospective, observational | Hospital | To determine the prevalence of MRSA and characterize the isolates at the University Hospital of the West Indies (UHWI) |
[35] | 1997-1998 | Trinidad | Prospective, observational | Hospital Community | To determine the prevalence of MRSA isolated from hospital and community practices and their anti-microbial resistance profiles |
[36] | 2005-2006 | Trinidad | Prospective, observational | Hospital | To investigate the prevalence of mupirocin resistance among clinical isolates of MRSA at SFGH |
[37] | 2000-2001 | Trinidad and Tobago | Retrospective | Hospital | To delineate and document the clonal relatedness of all MRSA clinical isolates |
[38] | 2013 | Guyana | Prospective | Hospital | To determine the prevalence and molecular characteristics of MRSA isolates |